Skip to content

Nutritional Management of Post COVID-19 Cognitive Symptoms

Nutritional Management of Post COVID-19 Cognitive Symptoms

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05705648
Enrollment
100
Registered
2023-01-31
Start date
2023-10-01
Completion date
2027-03-01
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long COVID

Keywords

brain fog; confusion; memory loss; functional decline

Brief summary

The goal of this clinical trial is to learn about in brain fog complaints associated with long-COVID in people aged 22-50-years. The main questions it aims to answer are: * the natural course of brain fog complaints * the effect, if any of supplemental dietary oil on brain fog complaints Participants will be asked to undergo some brain testing (X-rays and questions. Treatments they'll be given will be one of two supplemental oils to consume daily. Researchers will compare outcomes in the two different oil groups to see if it has any effect on brain fog complaints.

Detailed description

Randomized placebo-control clinical trial comparing two types of nutritional oil and evaluating the impact, if any, on subjective complaints of long-COVID cognitive changes.

Interventions

Medium chain triglyceride oil

DIETARY_SUPPLEMENTSafflower oil

Safflower oil

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double-blind, placebo control

Intervention model description

Randomised placebo-controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
22 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* confirmed COVID infection, at least 3 months previously, with ongoing cognitive complaints * all other medical conditions stable, and on stable doses of medications (if required)

Exclusion criteria

* COVID infection not confirmed by PCR or Rapid test * unable to speak English * pre-COVID cognitve complaints, and/or medical diagnoses affecting cognitive function

Design outcomes

Primary

MeasureTime frameDescription
Cognigram(R)12-monthscomputer-based cognitive test

Secondary

MeasureTime frameDescription
Montreal Cognitive Assessment12-monthsCognitive test

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026